Physician profile
Laszlo Fuzesi
NPI 1053305581
$3,885.60
in general payments reported to CMS, 2019-2025
17 companies · $331 in 2025
The $331 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $575 · 2020: $153 · 2021: $703 · 2022: $736 · 2023: $1,100 · 2024: $288 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,718.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $2,230.45 | 2019-2025 | Synergy Ablation System |
| Abiomed | $353.74 | 2019-2025 | Impella |
| Janssen Pharmaceuticals, INC | $325.29 | 2019-2024 | Xarelto |
| Edwards Lifesciences Corporation | $271.53 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $145.47 | 2021-2024 | |
| Amgen INC. | $122.17 | 2019-2023 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.10 | 2019-2023 | Jardiance |
| Lsi Solutions INC | $77.63 | 2025 | Cor-Knot |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $53.13 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $42.99 | 2023-2024 | Uptravi, Opsumit |
| Zimmer Biomet Holdings, INC. | $40.06 | 2019 | |
| Pfizer INC. | $29.80 | 2023-2024 | |
| Terumo Cardiovascular Systems Corporation | $26.57 | 2019 | |
| Medtronic, INC. | $23.06 | 2024 | Microstream |
| Medtronic Vascular, INC. | $19.04 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $16.64 | 2019 | |
| Chiesi USA, INC. | $12.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laszlo Fuzesi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.